Nexien BioPharma Inc (NXEN)

[GOIN/Green]

Truthfully with having traded for 6 dollars a share not that long ago i could see a run that high and a retrace above 2 bucks with the cse listing. FDA approval for the orphan drug study for chemical warfare treatment could mean double digits simply because the float is locked up already and likely will be until we reach a pps reasonable for the float. i honestly dont expect to see much liquidity until well above 2 bucks a share. those holding are Private Placement and it doesnt make sense to sell the bulk of your shares below your last Warrant. So expect the float to be locked until at least above 2 bucks. JMHO